Figure 2
Figure 2. Survival and proliferation of primary CD138+ MM cells in culture. (A) Primary CD138+ MM cells were cultured for 72 hours in RPMI with either 10% FCS or 20% plasma pooled from MM patients (CM). Viable CD138+ cells after 72 hours, expressed as a percentage of the initial viable CD138+ population (mean ± SEM, n = 38; 6 of whom had circulating plasma cells). (B) CD138+ cells were cultured in RPMI alone (0%), RPMI/10% FCS, or CM for 72 hours. Viability was determined using annexin V/PI staining and FACS analysis, viable fraction was annexin V–/PI-negative (n = 14, 1 with circulating plasma cells). (C) Four representative cases from panel B are shown (percentage indicates viable fraction). (D) Absolute number of CD138+ cells in S/G2M (proliferative fraction) at the time of isolation (0 hours) and after 72 hours culture in either 10% FCS or CM. Data are presented as mean ± SEM (n = 34, 6 with circulating plasma cells).

Survival and proliferation of primary CD138+ MM cells in culture. (A) Primary CD138+ MM cells were cultured for 72 hours in RPMI with either 10% FCS or 20% plasma pooled from MM patients (CM). Viable CD138+ cells after 72 hours, expressed as a percentage of the initial viable CD138+ population (mean ± SEM, n = 38; 6 of whom had circulating plasma cells). (B) CD138+ cells were cultured in RPMI alone (0%), RPMI/10% FCS, or CM for 72 hours. Viability was determined using annexin V/PI staining and FACS analysis, viable fraction was annexin V–/PI-negative (n = 14, 1 with circulating plasma cells). (C) Four representative cases from panel B are shown (percentage indicates viable fraction). (D) Absolute number of CD138+ cells in S/G2M (proliferative fraction) at the time of isolation (0 hours) and after 72 hours culture in either 10% FCS or CM. Data are presented as mean ± SEM (n = 34, 6 with circulating plasma cells).

Close Modal

or Create an Account

Close Modal
Close Modal